Virus Testing Diagnostic Kits Market Analysis

  • Report ID: 2414
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Virus Testing Diagnostic Kits Market Analysis

The virus testing kits market is segmented by test type, by application, by end user and by region. The test type segment is further segmented into direct fluorescent antibody [DFA] test, immunochromatographic assay, reverse transcriptase polymerase chain reaction [RT-PCR] based test, agglutination assay, solid phase assay, flow through assay and others. Based on this, the segment for immunochromatographic assay is anticipated to hold the leading share in the market on account of high demand for these testing kits and better reimbursement policies by the government. The reverse transcriptase polymerase chain reaction [RT-PCR] based test segment, on the other hand, is anticipated to grow at the highest rate in the market as a result of increasing demand for these virus testing and diagnostic kits for testing of the new coronavirus disease, COVID-19. According to the World Health Organization, as of April 7, 2020, there were around 1,279,723 confirmed cases and 72,616 confirmed deaths due to COVID-19 in the world. The disease spread to 211 countries or territories globally and resulted in a global pandemic

Our in-depth analysis of the global market includes the following segments:

By Test Type

  • Direct Fluorescent Antibody [DFA] Test
  • Immunochromatographic Assay
  • Reverse Transcriptase Polymerase Chain Reaction [RT-PCR] Based Test
  • Agglutination Assay
  • Solid Phase Assay
  • Flow Through Assay 
  • Others

By Application

  • HIV
  • Hepatitis
  • Influenza
  • Measles
  • Others

By End User

  • Research Laboratories
  • Hospitals
  • Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2414
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of diseases arising as a result of newly discovered viruses and improving healthcare infrastructure is driving the market growth

The market is anticipated to attain a significant CAGR over the forecast period, i.e. 2020-2028.

Asia Pacific region is predicted to provide more business opportunities for growth on account of of developing healthcare infrastructure, growing research activities and improving healthcare facilities in the region.

The major players in the market are F. Hoffmann-La Roche Ltd, Qiagen, Abbott, Thermo Fisher Scientific, Becton, Dickinson and Company, BioMérieux SA, Quidel Corporation, Rapikit, Zoetis Inc. and Luminex Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample